DoD Aims to Shield Warfighters From Novel Biological Agents
The U.S. Department of Defense (DoD) is modernizing its approach for developing medical countermeasures to protect Warfighters from novel biological agents. This is made clear in a new document, “Approach for Research, Development, and Acquisition of Medical Countermeasures and Test Products,” which was recently published by the Office of the Deputy Assistant Secretary of Defense…